Olmesartan — Discount Pricing

Other medications in Heart & Cardiovascular

• Perindopril
• Pindolol
• Pitavastatin
• Pravastatin
• Propafenone
• Quinapril
• Ramipril
• Ranolazine

About Olmesartan

Olmesartan is a widely prescribed medication used to manage high blood pressure, a common condition that can lead to serious health issues if left untreated. By effectively lowering blood pressure, olmesartan helps protect your heart and overall well-being. At TheDrugClub, we believe essential medications like olmesartan should be accessible and affordable for everyone, helping you save significantly on your prescription costs.

What Olmesartan Treats

Olmesartan is primarily prescribed to treat high blood pressure, also known as hypertension. Hypertension is a widespread condition where the force of blood against your artery walls is consistently too high. Left untreated, it can lead to severe health problems such as heart attack, stroke, kidney disease, and heart failure. By effectively lowering and maintaining healthy blood pressure levels, olmesartan plays a crucial role in preventing these serious complications and supporting long-term cardiovascular health.

How Olmesartan Works

Olmesartan belongs to a class of medications called Angiotensin Receptor Blockers (ARBs). Its mechanism of action involves blocking the effects of a natural substance in your body called angiotensin II. Angiotensin II normally causes blood vessels to narrow and constrict, which increases blood pressure. By blocking the receptors where angiotensin II binds, olmesartan allows blood vessels to relax and widen. This widening of blood vessels reduces the overall resistance to blood flow, thereby lowering blood pressure. This action helps your heart pump blood more easily throughout your body.

Typical Costs of Olmesartan

The cost of olmesartan can vary significantly depending on whether you purchase the brand-name version (Benicar) or its generic equivalent, your pharmacy, and your insurance coverage. Without insurance, a typical 30-day supply of generic olmesartan can range anywhere from $15 to $50 or more. Brand-name versions are considerably more expensive, often costing hundreds of dollars per month. Even with insurance, many patients face co-pays or deductibles that can make managing this essential medication a financial burden.

How TheDrugClub Members Get Olmesartan for $0 Co-Pay

At TheDrugClub, we're dedicated to making vital medications like olmesartan affordable and convenient. As a member, you can receive your olmesartan

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Olmesartan is approved for (FDA label)

Olmesartan medoxomil tablets are indicated for the treatment of hypertension in adults and children six years of age and older, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with olmesartan medoxomil. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake.

Source: Read the full FDA label on DailyMed. Label effective date: August 27, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Boxed warning for Olmesartan (FDA label)

WARNING: FETAL TOXICITY When pregnancy is detected, discontinue olmesartan medoxomil as soon as possible (5.1 , 8.1) . Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus (5.1 , 8.1) . WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue olmesartan medoxomil as soon as possible (5.1 , 8.1) . Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus (5.1 , 8.1) .

Source: FDA prescribing information (DailyMed). Set ID: 1be698df-30a0-4117-8c24-7253af94c8ad. SPL document ID: 5a06faa6-514c-2f36-e063-6294a90aee80. Label effective date: August 27, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Dosage forms and strengths for Olmesartan (FDA label)

40 mg white, oval, film coated tablets, debossed with “SG” on one side and “341” on other side. Tablets: 40 mg (3) .

Source: FDA prescribing information (DailyMed). Set ID: 1be698df-30a0-4117-8c24-7253af94c8ad. SPL document ID: 5a06faa6-514c-2f36-e063-6294a90aee80. Label effective date: August 27, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Olmesartan (FDA label)

The most common adverse reaction in adults was dizziness (3%) (6.1) . To report SUSPECTED ADVERSE REACTIONS, contact ScieGen Pharmaceuticals, Inc. at 1-855-724-3436 or FDA at 1-800-332-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice. Adult Hypertension Olmesartan medoxomil has been evaluated for safety in more than 3825 patients/subjects, including more than 3275 patients treated for hypertension in controlled trials.

Source: FDA prescribing information (DailyMed). Set ID: 1be698df-30a0-4117-8c24-7253af94c8ad. SPL document ID: 5a06faa6-514c-2f36-e063-6294a90aee80. Label effective date: August 27, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.